In response to SLE sera, the median APOL1 expression increased 6.0 (2.8 to 39.8)-fold compared to 2.0 (0.9 to 5.3)-fold in healthy control sera (SLE sera-treated vs. HC sera treated, p = 0.01). The gene discussed is APOL1; the disease is systemic lupus erythematosus.